May 10 (Reuters)-
Haba Laboratories Inc
CONSOLIDATED FINANCIAL HIGHLIGHTS
(in billions of yen unless specified)
Year ended Year ended Year to NEXT
Mar 31, 2019 Mar 31, 2018 Mar 31, 2020 YEAR
LATEST YEAR-AGO COMPANY COMPANY
RESULTS RESULTS FORECAST H1 FORECAST
Sales 19.25 17.89 20.10
(+7.6 pct) (+10.8 pct) (+4.4 pct)
Operating 3.10 2.40 3.18
(+28.9 pct) (+35.6 pct) (+2.7 pct)
Recurring 3.10 2.39 3.17
(+29.7 pct) (+36.7 pct) (+2.2 pct)
Net
Net 2.09 1.60 2.16
(+30.7 pct) (+31.7 pct) (+3.4 pct)
EPS 530.93 yen 406.20 yen 549.12 yen
Ann Div 40.00 yen 30.00 yen 40.00 yen
-Q2 Div NIL NIL NIL
-Q4 Div 40.00 yen 30.00 yen 40.00 yen
NOTE - Haba Laboratories Inc.
*Second Net profit row denotes profit attributable to owners ofthe parent
To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4925.T